ABSTRACT
J.M.K. Murthy Epilepsy, one of the most common neurologic disorders, affects approximately
1% of the world population. Over four-fifth of the 50 million people with epilepsy are thought to be in developing countries.1 Epilepsy care varies widely from country to country and also from one region to another within the country. In developed countries with well-structured health care and reimbursement systems, antiepileptic drug (AED) prescription is evidence-based, whereas in developing countries cul tural attitudes, a lack of prioritisation, poor health care infrastructure, and inad equate supplies of AEDs all conspire to hinder appropriate treatment.1
